Statkevicius Svajunas, Frigyesi Attila, Bentzer Peter
Department of Anesthesia and Intensive Care, Skåne University Hospital, Lund, Sweden.
Department of Clinical Sciences, Lund University, Lund, Sweden.
Intensive Care Med Exp. 2017 Oct 26;5(1):50. doi: 10.1186/s40635-017-0160-3.
Even though crystalloids are the first choice for fluid resuscitation in hemodynamically unstable patients, their potency as plasma volume expanders in hypovolemia of different etiologies is largely unknown. The objective of the study was to investigate dose-response curves of a crystalloid in hypovolemia induced by either sepsis or hemorrhagic shock.
Rats were randomized to resuscitation with Ringers acetate at a dose 10, 30, 50, 75, or 100 ml/kg at 4 h after induction of sepsis by cecal ligation and puncture (CLP) or 2.5 h after a 30 ml/kg hemorrhage. Plasma volume (I-albumin) was the primary outcome. Plasma volume decreased by about 11.8 (IQR 9.9-14.5) ml/kg relative baseline after CLP and increased dose-dependently by at most 5.8 (IQR 3.3-7.0) ml/kg in the 100 ml/kg group at 15 min after resuscitation. In the hemorrhage group, the plasma volume increased by at most 13.8 (IQR 7.1-15.0) ml/kg in 100 ml/kg group. Blood volumes at baseline, calculated using hematocrit and plasma volumes, were 72.4 (IQR 68.2-79.5) ml/kg in sepsis group and 71.1 (IQR 69.1-74.7) ml/kg in hemorrhage group. At 15 min after resuscitation with a dose of 100 ml/kg blood volumes increased to 54.8 (IQR 52.5-57.7) ml/kg and ; 49.6 (IQR 45.3-56.4) ml/kg, in the sepsis and hemorrhage groups, respectively. Plasma volume expansion as the percentage of dose at 15 min was 5.9 (IQR 2.5-8.8)% and 14.5 (IQR 12.1-20.0)% in the sepsis and hemorrhage groups, respectively. At 60 min, average plasma volume as the percentage of dose had decreased to 2.9 (IQR ([-2.9] - 8.3)% (P = 0.006) in the sepsis group whereas no change was detected in the hemorrhage group. A dose-dependent decrease in the plasma oncotic pressure, which was more marked in sepsis, was detected at 60 min after resuscitation.
We conclude that the efficacy of Ringers acetate as a plasma volume expander is context dependent and that plasma volume expansion is lower than previously realized across a wide range of doses. Ringers acetate decreases plasma oncotic pressure in sepsis, in part, by mechanisms other than dilution.
尽管晶体液是血流动力学不稳定患者液体复苏的首选,但在不同病因引起的低血容量状态下,其作为血浆容量扩充剂的效能很大程度上尚不明确。本研究的目的是探讨晶体液在脓毒症或失血性休克所致低血容量状态下的剂量 - 反应曲线。
通过盲肠结扎和穿刺(CLP)诱导脓毒症4小时后或30 ml/kg出血2.5小时后,将大鼠随机分为接受剂量为10、30、50、75或100 ml/kg的醋酸林格液复苏组。血浆容量(I - 白蛋白)为主要观察指标。CLP后血浆容量相对于基线下降约11.8(四分位间距9.9 - 14.5)ml/kg,复苏后15分钟,100 ml/kg组血浆容量最多剂量依赖性增加5.8(四分位间距3.3 - 7.0)ml/kg。在出血组,100 ml/kg组血浆容量最多增加13.8(四分位间距7.1 - 15.0)ml/kg。使用血细胞比容和血浆容量计算的基线血容量,脓毒症组为72.4(四分位间距68.2 - 79.5)ml/kg,出血组为71.1(四分位间距69.1 - 74.7)ml/kg。在100 ml/kg剂量复苏后15分钟,脓毒症组和出血组血容量分别增加至54.8(四分位间距52.5 - 57.7)ml/kg和49.6(四分位间距45.3 - 56.4)ml/kg。复苏后15分钟,脓毒症组和出血组血浆容量扩充占剂量的百分比分别为5.9(四分位间距2.5 - 8.8)%和14.5(四分位间距12.1 - 20.0)%。60分钟时,脓毒症组平均血浆容量占剂量的百分比降至2.9(四分位间距[-2.9] - 8.3)%(P = 0.006),而出血组未检测到变化。复苏后60分钟检测到血浆胶体渗透压呈剂量依赖性下降,在脓毒症中更明显。
我们得出结论,醋酸林格液作为血浆容量扩充剂的疗效取决于具体情况,并且在广泛的剂量范围内,血浆容量扩充低于先前的认识。醋酸林格液在脓毒症中降低血浆胶体渗透压,部分是通过稀释以外的机制。